Kun‐Ju Lin

9.6k citations

247 papers · 7.5k indexed · 1 hit paper · h-index 46

Impact in

Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery

Papers in

Pharmaceutical Science 16
- Advanced Drug Delivery Systems 16
Psychiatry and Mental health 35
- Dementia and Cognitive Impairment Research 32

Co-authors: Hsing‐Wen Sung Tzu‐Chen Yen Shiaw‐Pyng Wey Ing‐Tsung Hsiao Er‐Yuan Chuang Kiran Sonaje Wei‐Tso Chia M. Chung
Journals: Biomaterials (32 papers)Nuclear Medicine and Biology (11 papers)Scientific Reports (8 papers)European Journal of Nuclear Medicine and Molecular Imaging (7 papers)PLoS ONE (6 papers)
Partner nations: Taiwan United States China

In The Last Decade

Kun‐Ju Lin

233 papers receiving 7.4k citations

Hit Papers

align trajectories log scale

Magnetic ResonanceImages Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction inAlzheimer Disease 2022 · 145 citations

Peers

Countries citing papers authored by Kun‐Ju Lin

Since Specialization

Citations

This map shows the geographic impact of Kun‐Ju Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Ju Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Ju Lin more than expected).

Fields of papers citing papers by Kun‐Ju Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Ju Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Ju Lin. The network helps show where Kun‐Ju Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kun‐Ju Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kun‐Ju Lin Line = papers co-authored together Kun‐Ju Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Taiwan‐ADNI workflow toward integrating plasma p‐tau217 into prediction models for the risk of Alzheimer's disease and tau burden Alzheimer s & Dementia ·Kuo‐Lun Huang, Ing‐Tsung Hsiao, Chi‐Wei Huang, Chung‐Guei Huang, Ph. May, Shu‐Hua Huang, Kun‐Ju Lin, Muhammad Fakhri Robbani, Chin‐Chang Huang, Chiung‐Chih Chang	2025	4
2	Allelopathy of extracellular chemicals released by Karlodinium veneficum on photosynthesis of Prorocentrum donghaiense Journal of Hazardous Materials ·Hafiz Shoaib Shakir, Yanru Wang, Kun‐Ju Lin, Liju Tan, Jenny Frueh	2024	4
3	Human biodistribution and radiation dosimetry for the tau tracer [18F]Florzolotau in healthy subjects EJNMMI Radiopharmacy and Chemistry ·Kun‐Ju Lin, Shao‐Yi Huang, Kuo‐Lun Huang, Chin‐Chang Huang, Ing‐Tsung Hsiao	2024	2
4	Dominance of Tau Burden in Cortical Over Subcortical Regions Mediates Glymphatic Activity and Clinical Severity in PSP Clinical Nuclear Medicine ·Jung‐Lung Hsu, Yi‐Chia Wei, Ing‐Tsung Hsiao, Kun‐Ju Lin, Tzu‐Chen Yen, Chin‐Song Lu, Hancheng Wang, Alexander Leemans, Yi-Hsin Weng, Kuo‐Lun Huang	2024	3
5	Spatiotemporal distribution, source analysis and ecological risk assessment of polychlorinated biphenyls (PCBs) in the Bohai Bay, China Marine Pollution Bulletin ·Shan Jiang, 蒋舟, Kun‐Ju Lin, Yanshan Chen, Rui Wang, Liju Tan, Jiangtao Wang	2023	11
6	Plasmon-activated water as a therapeutic strategy in Alzheimer’s disease by altering gut microbiota Aging ·Chia‐Hsiung Cheng, Yu‐Chuan Liu, Yu‐Chen S. H. Yang, Kun‐Ju Lin, Dean Wu, Yun‐Ru Liu, Chun‐Chao Chang, Chien‐Tai Hong, Chaur‐Jong Hu	2023	5
7	A low-energy emulsification platform based on a Diet Coke–Mentos reaction-derived bubbly flow for formulating various emulsions as drug carriers Biomaterials ·Yu‐Jung Lin, Hela Guesmi, Frank Häge Simon Hug, 구진웅, 篤司飯田, P Kote Amol, Hsin‐Lung Chen, М. Г. Атлуханов, Hao‐Ji Wei, Kun‐Ju Lin, Hsing‐Wen Sung	2023	3
8	Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal Diagnostics ·Κουκουνάρας Λιάγκης, Kung‐Chu Ho, Shih-Hsin Chen, Monique Crane, Lan‐Yan Yang, Kun‐Ju Lin, Jacob Neusner, Miaw‐Jene Liou	2022	13
9	Investigation of reactive astrogliosis effect on post-stroke cognitive impairment Journal of Neuroinflammation ·Kuo‐Lun Huang, Ing‐Tsung Hsiao, M.-Y. Ho, Jung‐Lung Hsu, Delia Turley, Ting‐Yu Chang, Chi‐Hung Liu, Chien-Hung Chang, Yi-Ming Wu, Kuan-Yi Wu, Shiaw‐Pyng Wey, Tzu‐Chen Yen, Nobuyuki Okamura, Tsong‐Hai Lee, Kun‐Ju Lin	2020	9
10	Downregulation of GSTM2 enhances gemcitabine chemosensitivity of pancreatic cancer in vitro and in vivo Pancreatology ·Lisi Peng, Ji Feiyang, Kun‐Ju Lin, Yao Yao, Yang Zhang, Thiruvengadam Arumugam, Takahiko Fujii, Hui Jiang, Liqi Sun, I. V. Samoilova, Zhaoshen Li, Craig D. Logsdon, Baoan Ji, Haojie Huang	2020	11
11	Tau PET With 18F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation Frontiers in Neurology ·Chin‐Chang Huang, Ing‐Tsung Hsiao, Paul Geissler, Paul Geissler, Yi‐Ching Weng, Kuo‐Lun Huang, Chi‐Hung Liu, Ting‐Yu Chang, Hsiu-Chuan Wu, Tzu‐Chen Yen, Kun‐Ju Lin	2019	6
12	An Intestinal “Transformers”-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs ACS Nano ·Er‐Yuan Chuang, Kun‐Ju Lin, 李君庆, Hsin‐Lung Chen, Yang‐Bao Miao, 伊豆辰夫, Chiung-Tong Chen, Jyuhn-Huarng Juang, Hsing‐Wen Sung	2018	31
13	Correlation between visual association memory test and structural changes in patients with Alzheimer's disease and amnestic mild cognitive impairment Journal of the Formosan Medical Association ·Kuo‐Lun Huang, Ing‐Tsung Hsiao, Hung‐Chou Kuo, Chia‐Ju Hsieh, Sacha Mitchell, 早紀藤田, Shiaw‐Pyng Wey, Tzu‐Chen Yen, Kun‐Ju Lin, Chin‐Chang Huang	2018	9
14	Progress of Brain Amyloid Deposition in Familial Alzheimer’s Disease with Taiwan D678H APP Mutation Journal of Alzheimer s Disease ·Yi‐Ching Weng, Ing‐Tsung Hsiao, Paul Geissler, Paul Geissler, Kuo‐Lun Huang, Chi‐Hung Liu, Ting‐Yu Chang, Tzu‐Chen Yen, Kun‐Ju Lin, Chin‐Chang Huang	2018	3
15	Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study European Journal of Nuclear Medicine and Molecular Imaging ·Kuan-Yi Wu, Chia-Yih Liu, Cheng‐Sheng Chen, Chia‐Hsiang Chen, Ing‐Tsung Hsiao, Chia‐Ju Hsieh, Chin‐Pang Lee, Tzu‐Chen Yen, Kun‐Ju Lin	2016	33
16	Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b Biomaterials ·Darshana Shirbhate, Yu‐Han Chang, Li‐Yu Sung, Kuei‐Chang Li, Chia-Lin Yeh, Tzu‐Chen Yen, Shiaw‐Min Hwang, Kun‐Ju Lin, Yu‐Chen Hu	2014	114
17	Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography European Journal of Nuclear Medicine and Molecular Imaging ·Kuan-Yi Wu, Ing‐Tsung Hsiao, Cheng‐Sheng Chen, Chia‐Hsiang Chen, Chia‐Ju Hsieh, Yau‐Yau Wai, Chee‐Jen Chang, Hsiao‐Jung Tseng, Mohammad Ahmadi, Chia-Yih Liu, Kun‐Ju Lin	2013	92
18	Amyloid plaque imaging from IMPY/SPECT to AV-45/PET Biomedical Journal ·Mei‐Ping Kung, Kun‐Ju Lin, Ing‐Tsung Hsiao, Chi-Chang Weng, Tzu‐Chen Yen, Shiaw‐Pyng Wey	2012	10
19	Validation of an Animal FDG PET Imaging System for Study of Glioblastoma Xenografted Mouse and Rat Models Tien-Jen Lin, Carrillo Carranza David Osvaldo, I‐Jen Wang, Jia‐Wei Lin, Kuo‐Sheng Hung, V Tzavara, ITEP SESSAD ASMH, Ning‐Sun Yang, Kun‐Ju Lin	2010	3
20	Mimicking Extensive Bone Metastases in FDG PET Scan in an Oral Cancer Patient with Polyostotic Fibrous Dysplasia Kung‐Chu Ho, Tzu‐Chen Yeh, Shu‐Hang Ng, Kun‐Ju Lin	2006	1

About Kun‐Ju Lin

Kun‐Ju Lin is a scholar working on Pharmaceutical Science, Psychiatry and Mental health, Radiology, Nuclear Medicine and Imaging, Neurology and Physiology, having authored 247 papers that have together received 7.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (41 papers), Dementia and Cognitive Impairment Research (32 papers), Medical Imaging Techniques and Applications (25 papers), Parkinson's Disease Mechanisms and Treatments (21 papers), Nanoparticle-Based Drug Delivery (18 papers), Neurological disorders and treatments (17 papers), Advanced Drug Delivery Systems (16 papers) and Functional Brain Connectivity Studies (16 papers). The work is most often cited by research in Pharmaceutical Science (1.0k citations), Biomaterials (1.3k citations), Biological Psychiatry (118 citations), Neurology (715 citations) and Biomedical Engineering (1.9k citations). Kun‐Ju Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Hsing‐Wen Sung, Tzu‐Chen Yen, Shiaw‐Pyng Wey, Ing‐Tsung Hsiao, Er‐Yuan Chuang, Kiran Sonaje, Tzu‐Chen Yen, Wei‐Tso Chia, M. Chung and Fang-Yi Su. Their work appears in journals such as Biomaterials, Nuclear Medicine and Biology, Scientific Reports, European Journal of Nuclear Medicine and Molecular Imaging and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact